Education
The Lyceum, Malta - 1965 to 1970
The Junior College, Royal University of Malta - 1970 to 1972
Royal University of Malta - 1972 to 1977
Qualifications
Academic
MD, University of Malta, 1984
MD (Research Doctorate), University of Newcastle upon Tyne, 1990
MA University of Cambridge, 1994
Professional
MRCS, LRCP Conjoint Examining Board 1977
MRCP Royal Colleges of Physicians 1981
MRCPath (Neuropathology) Royal College of Pathologists 1990
FRCPath Royal College of Pathologists 1999
FRCP Royal College of Physician of London 2007
FHEA Higher Education Academy 2007
General Medical Council Registration
Full registration on 28 Feb 1979
Registration number: 2402941
Professional History
- Present Appointments
University of Cambridge (since 2002): University Senior Lecturer in Pathology
Addenbrooke's NHS Trust (since 1991): Honorary Consultant Neuropathologist (Lead clinician in diagnostic neuropathology)
St Catharine's College (since 1994): Official Fellow & Dean (since 2002)
Director of Studies in Pathology - Previous Appointments
Jan 1978 – July 1978 House Physician (General Medicine), West Middlesex Hospital, Isleworth, Middlesex
Aug 1978 – Dec 1978 House Surgeon (General Surgery), Leicester General Hospital
Jan 1979 – Dec 1979 SHO in General Medicine, Wythenshawe Hospital, Manchester
Jan 1980 – Jan 1981 SHO in General Medicine, University Hospitals of South Manchester (Withington Hospital and Christie Hospital)
Feb 1981 – Jan 1982 Registrar in General Medicine, Manchester Royal Infirmary
Feb 1982 – Jan 1983 SHO in Neurology, Newcastle General Hospital
Feb 1983 – Jan 1985 Registrar in Neurology, Newcastle General Hospital
Feb 1985 – Aug 1987 Research Registrar in Neuropathology, Newcastle General Hospital
Sep 1987 – July 1991 Senior Registrar in Neuropathology, Addenbrooke’s Hospital, Cambridge
Aug 1991 – Sep 2002 University Lecturer in Pathology, University of Cambridge and
Honorary Consultant Neuropathologist, Addenbrooke’s Hospital, Cambridge
1991 - 2002 Director, Cambridge Brain Bank Laboratory
Professional Contributions
The Royal College of Pathologists, UK
Chair of the Board of Examiners for FRCPath (Neuropathology)
Member, Specialty Advisory Committee
European Congress of Neuropathological Societies (Euro CNS)
Secretary of the Board of Examiners for Accreditation in Neuropathology
British Medical Association
Member, Medical Academic Staff Committee
Clinical Pathology Accreditation (UK) Ltd
Member, Panel of Assessors
International Society of Neuropathology
Member
British Neuropathological Society
Member
Committee member 1999-2002
Royal Society of Medicine
Fellow
Council Member: Pathology section, 2003-05
Chair of the Board of Examiners for FRCPath (Neuropathology)
Member, Specialty Advisory Committee
European Congress of Neuropathological Societies (Euro CNS)
Secretary of the Board of Examiners for Accreditation in Neuropathology
British Medical Association
Member, Medical Academic Staff Committee
Clinical Pathology Accreditation (UK) Ltd
Member, Panel of Assessors
International Society of Neuropathology
Member
British Neuropathological Society
Member
Committee member 1999-2002
Royal Society of Medicine
Fellow
Council Member: Pathology section, 2003-05
Research Contributions
Collaborations
Part of my research effort is directed toward the Cambridge Brain Bank Laboratory, which includes a brain bank facility that underpins major grant-supported clinical and fundamental neuroscience research in Cambridge. I was Director of the Cambridge Brain Bank from 1991 till 2002 and was involved in major MRC-funded collaborations, which included:
- An epidemiological study of dementia in the Cambridge City over-75 Cohort (formerly Cambridge Project for Later Life) with Professors Paykel, Brayne and Huppert, among others
- The Multicentre Cognitive Function in Ageing study with Professors Paykel, Brayne, Huppert, Esiri and Ince, among others
- A study of Frontotemporal Dementia and Progressive Supranuclear Palsy, with Professors Hodges and Patterson and Drs Bak, Spillantini and Davies, among others
- A study which explores the relationship between Down’s syndrome and Alzheimer’s disease with Professor Holland.
Contributions
Through various collaborations, I have contributed to:
- The identification of the prevalence and incidence of dementia in the elderly population in Cambridge, with particular reference to Alzheimer’s disease and vascular disease
- The discovery that, in Alzheimer’s disease, compensatory changes in synaptic proteins precede tau pathology and the onset of clinical dementia
- The identification and characterization of cases of Alzheimer’s disease with atypical neuropsychological deficits
- The characterization of alternative clinical phenotypes in Alzheimer’s disease
- The identification of several genetic polymorphisms and a deletion mutation related to Alzheimer’s disease
- The discovery that tau gene mutation K257T can cause Pick’s disease
- An understanding of the relationship between IT15 CAG triplet repeat expansion and the clinical and neuropathological phenotypes in Huntington’s disease
- A description of the genomic organization of the human metabotropic glutamate receptor subtypes 3 and 5
- A description of up-regulation of astrocytic metabotropic glutamate receptors in an in vitro model of neurodegeneration
- An understanding of the neuropathological basis of fluent and non-fluent aphasia
- The discovery that the perirhinal cortex is the anatomical basis of semantic memory in the human.
Scientific Publications
Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR. The neural basis of semantic memory: Evidence from semantic dementia.Neurobiol Aging. 2008 Mar 24; [Epub ahead of print]
Downes EC, Robson J, Grailly E, Abdel-All Z, Xuereb J, Brayne C, Holland A,Honer WG, Mukaetova-Ladinska EB. Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol Appl Neurobiol. 2008 Feb; 34(1):12-22.
Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH,Pohl U. High grade glioma: Imaging combined with pathological grade defines managementand predicts prognosis. Radiother Oncol. 2007 Dec; 85(3):371-378.
Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR. Focal cortical presentations of Alzheimer's disease. Brain. 2007 Oct; 130(Pt 10):2636-45.
Corti C, Crepaldi L, Mion S, Roth AL, Xuereb JH, Ferraguti F. Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia. Biol Psychiatry. 2007 Oct 1; 62(7):747-55.
Santarius T, Chia HL, Xuereb JH, Kirollos RW. Sporadic malignant nerve sheath tumour of the oculomotor nerve. Acta Neurochir (Wien). 2007 Jun;149(6):617-622.
Nestor PJ, Balan K, Cheow HK, Fryer TD, Knibb JA, Xuereb JH, Hodges JR. Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia. Neurology. 2007 Jan 16;68(3):238-9.
Kersaitis C, Halliday GM, Xuereb JH, Pamphlett R, Bak TH, Hodges JR, Kril JJ. Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology. Neuropathol Appl Neurobiol. 2006 Feb; 32(1): 83-91.
Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006 Jan; 59(1):156-65.
Bak TH, Yancopoulou D, Nestor PJ, Xuereb JH, Spillantini MG, Pulvermuller F,Hodges JR. Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing. Brain. 2006 Feb; 129(Pt 2):321-32.
Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain. 2005 Sep; 128(Pt 9):1984-95.
Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG. Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol. 2005 Mar; 64(3):245-53.
Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5; 132(1):5-8.
Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S. A-beta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. 2005 Mar; 128(Pt 3):500-15.
Jamieson SE, White JK, Howson JM, Pask R, Smith AN, Brayne C, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC, Blackwell JM. Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci Lett. 2005 Feb 10; 374(2):124-8.
Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005 Mar; 128(Pt 3):597-605.
Davies RR, Graham KS, Xuereb JH, Williams GB, Hodges JR. The human perirhinal cortex and semantic memory. Eur J Neurosci. 2004 Nov; 20(9):2441-6.
Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004 Sep;56(3):399-406.
Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Pryer T, Guadagno JV, Warburton FA. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke. 2004 Jul; 35(7):1659-64. Epub 2004 May 20.
Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Owen MJ, Williams J, Lendon C, Rubinsztein DC.
Candidate gene association studies of the alpha4 (CHRNA4) and beta2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci Lett. 2004 Mar 25; 358(2):142-6.
Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol. 2004 Jan; 11(1):59-62.
Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003 Aug 12; 61(3):349-54.
Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F. Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells. J Biol Chem. 2003 Aug 29; 278(35):33105-19.
Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC. No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease. Ann Neurol. 2002 Nov; 52(5):690-1.
Taylor A, Ezquerra M, Bagri G, Yip A, Goumidi L, Cottel D, Easton D, Evans JG, Xuereb J, Cairns NJ, Amouyel P, Chartier-Harlin MC, Brayne C, Rubinsztein DC. Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes. Am J Med Genet. 2001 Dec 8; 105(8):761-4.
Corti C, Xuereb JH, Corsi M, Ferraguti F. Identification and characterization of the promoter region of the GRM3 gene. Biochem Biophys Res Commun. 2001 Aug 17; 286(2):381-7.
Corti C, Sala CF, Yang F, Corsi M, Xuereb JH, Ferraguti F. Genomic organization of the human metabotropic glutamate receptor subtype 3. J Neurogenet. 2000 Dec; 14(4):207-25, 271.
Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res. 2001 Mar; 137(1):1-11.
Harasty JA, Halliday GM, Xuereb J, Croot K, Bennett H, Hodges JR. Cortical degeneration associated with phonologic and semantic language impairments in AD. Neurology. 2001 Apr 10; 56(7):944-50.
Taylor AE, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC. Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet. 2001 Apr; 38(4):232-3.
Murphy T, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport. 2001 Mar 5; 12(3):631-4.
Lehmann DJ, Wiebusch H, Marshall SE, Johnston C, Warden DR, Morgan K, Schappert K, Poirier J, Xuereb J, Kalsheker N, Welsh KI, Smith AD. HLA class I, II & III genes in confirmed late-onset Alzheimer's disease. Neurobiol Aging. 2001 Jan-Feb; 22(1):71-7.
Bak TH, O'Donovan DG, Xuereb JH, Boniface S, Hodges JR. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain. 2001 Jan; 124(Pt 1):103-20.
Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM.
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain. 2000 Dec; 123 Pt 12:2467-74.
Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, Spillantini MG. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol. 2000 Nov; 59(11):990-1001.
Croot K, Hodges JR, Xuereb J, Patterson K. Phonological and articulatory impairment in Alzheimer's disease: a case series. Brain Lang. 2000 Nov; 75(2):277-309.
Narain Y, Yip A, Murphy T, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Furlong RA, Rubinsztein DC. The ACE gene and Alzheimer's disease susceptibility. J Med Genet. 2000 Sep; 37(9):695-7.
Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R, Brayne C, Huppert FA, Paykel ES, McGee M, Jakes R, Honer WG, Harrington CR, Wischik CM.
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol. 2000 Aug; 157(2):623-36
Mukaetova-Ladinska EB, Hurt J, Jakes R, Xuereb J, Honer WG, Wischik CM. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. J Neuropathol Exp Neurol. 2000 May; 59(5):408-17.
Cross JJ, Antoun NM, Laing RJ, Xuereb J. Imaging of compressive vertebral haemangiomas. Eur Radiol. 2000; 10(6):997-1002.
Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C, Mukaetova-Ladinska E, McGee MA, O'Sullivan A, O'Connor D, Paykel ES, Huppert FA. Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci. 2000 Apr; 903:490-6.
Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000 Mar; 123 Pt 3:484-98.
Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry. 2000 Mar; 68(3):304-12.
Dahiyat M, Cumming A, Harrington C, Wischik C, Xuereb J, Corrigan F, Breen G, Shaw D, St Clair D. Association between Alzheimer's disease and the NOS3 gene. Ann Neurol. 1999 Oct; 46(4):664-7.
Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet. 1999 Sep; 7(6):659-63.
Dow DJ, Lindsey N, Cairns NJ, Brayne C, Robinson D, Huppert FA, Paykel ES, Xuereb J, Wilcock G, Whittaker JL, Rubinsztein DC. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet. 1999 May; 22(1):16-7; author reply 21-2.
Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol. 1999 Jan; 45(1):25-32.
Ginsberg L, Xuereb JH, Gershfeld NL. Membrane instability, plasmalogen content, and Alzheimer's disease. J Neurochem. 1998 Jun; 70(6):2533-8.
Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, Mukaetova-Ladinska E, Arendt T, Wischik CM. Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (Berl). 1998 Feb; 95(2):154-8.
Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, Wilcock G, Rubinsztein DC. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet. 1998 Jan; 62(1):70-6.
Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.
Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol. 1997 Nov; 18(6):754-60.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Holland FJ, Maher ER.
A molecular, clinical, and immunohistochemical study of vestibular schwannoma. Otolaryngol Head Neck Surg. 1997 Apr; 116(4):426-30.
Tysoe C, Whittaker J, Cairns NJ, Atkinson PF, Harrington CR, Xuereb J, Wilcock G, Rubinsztein DC. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett. 1997 Jan 24; 222(1):68-9.
Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, Xuereb J, Wischik C, Harrington C, Kalsheker NA. Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet. 1997 Jan; 99(1):27-31.
Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR.
Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 Oct; 61(4):388-95.
Greene JD, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol. 1996 Oct; 53(10):1072-8.
Rigby M, Le Bourdelles B, Heavens RP, Kelly S, Smith D, Butler A, Hammans R, Hills R, Xuereb JH, Hill RG, Whiting PJ, Sirinathsinghji DJ. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 1996 Jul; 73(2):429-47.
Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia. 1996 May-Jun; 7(3):169-74.
Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J Neurosurg. 1996 May; 84(5):847-51.
Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry. 1996 Apr; 60(4):403-10.
Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Kruger H, McGee MA, Paykel ES, Harrington CR, Mukaetova-Ladinska EB, O'Connor DW, Wischik CM. The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci. 1996; 246(3):132-6.
Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease. J Neurol Neurosurg Psychiatry. 1996 Jan; 60(1):78-81.
Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett. 1995 Dec 29; 202(1-2):101-4.
Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 1995 Nov 6; 698(1-2):223-6.
Lai RY, Gertz HN, Wischik DJ, Xuereb JH, Mukaetova-Ladinska EB, Harrington CR, Edwards PC, Mena R, Paykel ES, Brayne C, et al. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiol Aging. 1995 May-Jun; 16(3):433-45.
Wischik CM, Edwards PC, Lai RY, Gertz HN, Xuereb JH, Paykel ES, Brayne C, Huppert FA, Mukaetova-Ladinska EB, Mena R, et al. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging. 1995 May-Jun; 16(3):409-17; discussion 418-31.
Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol. 1994 Dec; 145(6):1472-84.
Rubinsztein DC, Hanlon CS, Irving RM, Goodburn S, Evans DG, Kellar-Wood H, Xuereb JH, Bandmann O, Harding AE. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes. 1994 Dec; 8(6):519-25.
Guazzo EP, Xuereb JH. Spontaneous thrombosis of an arteriovenous malformation. J Neurol Neurosurg Psychiatry. 1994 Nov; 57(11):1410-2.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet. 1994 Feb; 3(2):347-50.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma. Arch Otolaryngol Head Neck Surg. 1993 Nov; 119(11):1222-8.
James S, Xuereb JH, Askalan R, Richardson PJ. Adenosine receptors in post-mortem human brain. Br J Pharmacol. 1992 Jan; 105(1):238
Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain. 1991 Jun; 114 (Pt 3):1363-79.
James S, Richardson PJ, Xuereb JH. Characterization and localization of the high affinity adenosine A2 receptor in rat and human brain. Biochem Soc Trans. 1991 Feb; 19(1):7S.
Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathol Appl Neurobiol. 1990 Dec; 16(6):477-88.
Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J Neurol Sci. 1990 Nov;99(2-3):185-97.
Wild AM, Xuereb JH, Marks PV, Gleave JR. Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br J Neurosurg. 1990; 4(5):407-15.
Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Adv Neurol. 1990; 53:35-40.
Dick DJ, Harris JB, Falkous G, Foster JB, Xuereb JH. Neuronal anti-nuclear antibody in paraneoplastic sensory neuronopathy. J Neurol Sci. 1988 May; 85(1):1-8.
Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. J Neural Transm Suppl. 1987; 24:131-6.
Downes EC, Robson J, Grailly E, Abdel-All Z, Xuereb J, Brayne C, Holland A,Honer WG, Mukaetova-Ladinska EB. Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol Appl Neurobiol. 2008 Feb; 34(1):12-22.
Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH,Pohl U. High grade glioma: Imaging combined with pathological grade defines managementand predicts prognosis. Radiother Oncol. 2007 Dec; 85(3):371-378.
Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR. Focal cortical presentations of Alzheimer's disease. Brain. 2007 Oct; 130(Pt 10):2636-45.
Corti C, Crepaldi L, Mion S, Roth AL, Xuereb JH, Ferraguti F. Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia. Biol Psychiatry. 2007 Oct 1; 62(7):747-55.
Santarius T, Chia HL, Xuereb JH, Kirollos RW. Sporadic malignant nerve sheath tumour of the oculomotor nerve. Acta Neurochir (Wien). 2007 Jun;149(6):617-622.
Nestor PJ, Balan K, Cheow HK, Fryer TD, Knibb JA, Xuereb JH, Hodges JR. Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia. Neurology. 2007 Jan 16;68(3):238-9.
Kersaitis C, Halliday GM, Xuereb JH, Pamphlett R, Bak TH, Hodges JR, Kril JJ. Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology. Neuropathol Appl Neurobiol. 2006 Feb; 32(1): 83-91.
Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006 Jan; 59(1):156-65.
Bak TH, Yancopoulou D, Nestor PJ, Xuereb JH, Spillantini MG, Pulvermuller F,Hodges JR. Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing. Brain. 2006 Feb; 129(Pt 2):321-32.
Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain. 2005 Sep; 128(Pt 9):1984-95.
Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG. Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol. 2005 Mar; 64(3):245-53.
Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5; 132(1):5-8.
Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S. A-beta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. 2005 Mar; 128(Pt 3):500-15.
Jamieson SE, White JK, Howson JM, Pask R, Smith AN, Brayne C, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC, Blackwell JM. Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci Lett. 2005 Feb 10; 374(2):124-8.
Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005 Mar; 128(Pt 3):597-605.
Davies RR, Graham KS, Xuereb JH, Williams GB, Hodges JR. The human perirhinal cortex and semantic memory. Eur J Neurosci. 2004 Nov; 20(9):2441-6.
Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004 Sep;56(3):399-406.
Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Pryer T, Guadagno JV, Warburton FA. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke. 2004 Jul; 35(7):1659-64. Epub 2004 May 20.
Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Owen MJ, Williams J, Lendon C, Rubinsztein DC.
Candidate gene association studies of the alpha4 (CHRNA4) and beta2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci Lett. 2004 Mar 25; 358(2):142-6.
Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol. 2004 Jan; 11(1):59-62.
Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003 Aug 12; 61(3):349-54.
Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F. Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells. J Biol Chem. 2003 Aug 29; 278(35):33105-19.
Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC. No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease. Ann Neurol. 2002 Nov; 52(5):690-1.
Taylor A, Ezquerra M, Bagri G, Yip A, Goumidi L, Cottel D, Easton D, Evans JG, Xuereb J, Cairns NJ, Amouyel P, Chartier-Harlin MC, Brayne C, Rubinsztein DC. Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes. Am J Med Genet. 2001 Dec 8; 105(8):761-4.
Corti C, Xuereb JH, Corsi M, Ferraguti F. Identification and characterization of the promoter region of the GRM3 gene. Biochem Biophys Res Commun. 2001 Aug 17; 286(2):381-7.
Corti C, Sala CF, Yang F, Corsi M, Xuereb JH, Ferraguti F. Genomic organization of the human metabotropic glutamate receptor subtype 3. J Neurogenet. 2000 Dec; 14(4):207-25, 271.
Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res. 2001 Mar; 137(1):1-11.
Harasty JA, Halliday GM, Xuereb J, Croot K, Bennett H, Hodges JR. Cortical degeneration associated with phonologic and semantic language impairments in AD. Neurology. 2001 Apr 10; 56(7):944-50.
Taylor AE, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC. Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet. 2001 Apr; 38(4):232-3.
Murphy T, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport. 2001 Mar 5; 12(3):631-4.
Lehmann DJ, Wiebusch H, Marshall SE, Johnston C, Warden DR, Morgan K, Schappert K, Poirier J, Xuereb J, Kalsheker N, Welsh KI, Smith AD. HLA class I, II & III genes in confirmed late-onset Alzheimer's disease. Neurobiol Aging. 2001 Jan-Feb; 22(1):71-7.
Bak TH, O'Donovan DG, Xuereb JH, Boniface S, Hodges JR. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain. 2001 Jan; 124(Pt 1):103-20.
Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM.
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain. 2000 Dec; 123 Pt 12:2467-74.
Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, Spillantini MG. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol. 2000 Nov; 59(11):990-1001.
Croot K, Hodges JR, Xuereb J, Patterson K. Phonological and articulatory impairment in Alzheimer's disease: a case series. Brain Lang. 2000 Nov; 75(2):277-309.
Narain Y, Yip A, Murphy T, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Furlong RA, Rubinsztein DC. The ACE gene and Alzheimer's disease susceptibility. J Med Genet. 2000 Sep; 37(9):695-7.
Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R, Brayne C, Huppert FA, Paykel ES, McGee M, Jakes R, Honer WG, Harrington CR, Wischik CM.
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol. 2000 Aug; 157(2):623-36
Mukaetova-Ladinska EB, Hurt J, Jakes R, Xuereb J, Honer WG, Wischik CM. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. J Neuropathol Exp Neurol. 2000 May; 59(5):408-17.
Cross JJ, Antoun NM, Laing RJ, Xuereb J. Imaging of compressive vertebral haemangiomas. Eur Radiol. 2000; 10(6):997-1002.
Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C, Mukaetova-Ladinska E, McGee MA, O'Sullivan A, O'Connor D, Paykel ES, Huppert FA. Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci. 2000 Apr; 903:490-6.
Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000 Mar; 123 Pt 3:484-98.
Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry. 2000 Mar; 68(3):304-12.
Dahiyat M, Cumming A, Harrington C, Wischik C, Xuereb J, Corrigan F, Breen G, Shaw D, St Clair D. Association between Alzheimer's disease and the NOS3 gene. Ann Neurol. 1999 Oct; 46(4):664-7.
Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet. 1999 Sep; 7(6):659-63.
Dow DJ, Lindsey N, Cairns NJ, Brayne C, Robinson D, Huppert FA, Paykel ES, Xuereb J, Wilcock G, Whittaker JL, Rubinsztein DC. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet. 1999 May; 22(1):16-7; author reply 21-2.
Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol. 1999 Jan; 45(1):25-32.
Ginsberg L, Xuereb JH, Gershfeld NL. Membrane instability, plasmalogen content, and Alzheimer's disease. J Neurochem. 1998 Jun; 70(6):2533-8.
Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, Mukaetova-Ladinska E, Arendt T, Wischik CM. Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (Berl). 1998 Feb; 95(2):154-8.
Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, Wilcock G, Rubinsztein DC. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet. 1998 Jan; 62(1):70-6.
Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.
Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol. 1997 Nov; 18(6):754-60.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Holland FJ, Maher ER.
A molecular, clinical, and immunohistochemical study of vestibular schwannoma. Otolaryngol Head Neck Surg. 1997 Apr; 116(4):426-30.
Tysoe C, Whittaker J, Cairns NJ, Atkinson PF, Harrington CR, Xuereb J, Wilcock G, Rubinsztein DC. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett. 1997 Jan 24; 222(1):68-9.
Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, Xuereb J, Wischik C, Harrington C, Kalsheker NA. Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet. 1997 Jan; 99(1):27-31.
Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR.
Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 Oct; 61(4):388-95.
Greene JD, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol. 1996 Oct; 53(10):1072-8.
Rigby M, Le Bourdelles B, Heavens RP, Kelly S, Smith D, Butler A, Hammans R, Hills R, Xuereb JH, Hill RG, Whiting PJ, Sirinathsinghji DJ. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 1996 Jul; 73(2):429-47.
Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia. 1996 May-Jun; 7(3):169-74.
Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J Neurosurg. 1996 May; 84(5):847-51.
Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry. 1996 Apr; 60(4):403-10.
Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Kruger H, McGee MA, Paykel ES, Harrington CR, Mukaetova-Ladinska EB, O'Connor DW, Wischik CM. The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci. 1996; 246(3):132-6.
Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS. Neuropathological diagnosis and CAG repeat expansion in Huntington's disease. J Neurol Neurosurg Psychiatry. 1996 Jan; 60(1):78-81.
Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett. 1995 Dec 29; 202(1-2):101-4.
Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 1995 Nov 6; 698(1-2):223-6.
Lai RY, Gertz HN, Wischik DJ, Xuereb JH, Mukaetova-Ladinska EB, Harrington CR, Edwards PC, Mena R, Paykel ES, Brayne C, et al. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiol Aging. 1995 May-Jun; 16(3):433-45.
Wischik CM, Edwards PC, Lai RY, Gertz HN, Xuereb JH, Paykel ES, Brayne C, Huppert FA, Mukaetova-Ladinska EB, Mena R, et al. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging. 1995 May-Jun; 16(3):409-17; discussion 418-31.
Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol. 1994 Dec; 145(6):1472-84.
Rubinsztein DC, Hanlon CS, Irving RM, Goodburn S, Evans DG, Kellar-Wood H, Xuereb JH, Bandmann O, Harding AE. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes. 1994 Dec; 8(6):519-25.
Guazzo EP, Xuereb JH. Spontaneous thrombosis of an arteriovenous malformation. J Neurol Neurosurg Psychiatry. 1994 Nov; 57(11):1410-2.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet. 1994 Feb; 3(2):347-50.
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma. Arch Otolaryngol Head Neck Surg. 1993 Nov; 119(11):1222-8.
James S, Xuereb JH, Askalan R, Richardson PJ. Adenosine receptors in post-mortem human brain. Br J Pharmacol. 1992 Jan; 105(1):238
Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain. 1991 Jun; 114 (Pt 3):1363-79.
James S, Richardson PJ, Xuereb JH. Characterization and localization of the high affinity adenosine A2 receptor in rat and human brain. Biochem Soc Trans. 1991 Feb; 19(1):7S.
Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathol Appl Neurobiol. 1990 Dec; 16(6):477-88.
Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J Neurol Sci. 1990 Nov;99(2-3):185-97.
Wild AM, Xuereb JH, Marks PV, Gleave JR. Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br J Neurosurg. 1990; 4(5):407-15.
Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Adv Neurol. 1990; 53:35-40.
Dick DJ, Harris JB, Falkous G, Foster JB, Xuereb JH. Neuronal anti-nuclear antibody in paraneoplastic sensory neuronopathy. J Neurol Sci. 1988 May; 85(1):1-8.
Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. J Neural Transm Suppl. 1987; 24:131-6.
Subscribe to:
Posts (Atom)
